Box score
Cloverleaf Bio, Inc.
Reported $14.8M sold in a new Form D filed September 9, 2026 (New Haven, Connecticut).
- Biggest raise
- $14.8M filed Sep 9, 2026
- League
- Bio & Health Biotechnology
- Based in
- New Haven, Connecticut
- Season rank
- #149 of 1,121 in the Bio & Health League; #1343 of 10,745 overall (2026)
- Incorporated
- 2023
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-09-09 | New notice | $14.8M | $29.6M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2153574.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Quarry Heme, Inc rookie | Bio & Health | $13.5M |
| 2 | Convexity Scientific Inc. | Bio & Health | $10M |
| 3 | Oncosynergy, Inc. | Bio & Health | $6.6M |
| 4 | Nanoviricides, Inc. | Bio & Health | $6M |
| 5 | TECLens, Inc. | Bio & Health | $5.2M |
| 6 | Allyx Therapeutics, Inc. | Bio & Health | $3.3M |